Your browser is no longer supported. Please, upgrade your browser.
CRNX Crinetics Pharmaceuticals, Inc. weekly Stock Chart
CRNX [NASD]
Crinetics Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.42 Insider Own0.60% Shs Outstand24.49M Perf Week-5.50%
Market Cap509.12M Forward P/E- EPS next Y-2.70 Insider Trans190.85% Shs Float27.71M Perf Month-16.33%
Income-58.80M PEG- EPS next Q-0.57 Inst Own72.50% Short Float4.85% Perf Quarter-21.31%
Sales0.90M P/S565.69 EPS this Y-86.10% Inst Trans-0.87% Short Ratio8.96 Perf Half Y-18.84%
Book/sh4.43 P/B3.49 EPS next Y-9.00% ROA-42.60% Target Price- Perf Year-41.40%
Cash/sh3.43 P/C4.51 EPS next 5Y- ROE-47.30% 52W Range10.63 - 28.81 Perf YTD-38.34%
Dividend- P/FCF- EPS past 5Y- ROI-46.00% 52W High-46.29% Beta-
Dividend %- Quick Ratio10.90 Sales past 5Y- Gross Margin- 52W Low45.53% ATR1.37
Employees68 Current Ratio10.90 Sales Q/Q-75.00% Oper. Margin- RSI (14)39.22 Volatility7.25% 8.64%
OptionableNo Debt/Eq0.00 EPS Q/Q-89.50% Profit Margin- Rel Volume1.86 Prev Close15.92
ShortableYes LT Debt/Eq0.00 EarningsJun 08 AMC Payout- Avg Volume150.16K Price15.47
Recom2.00 SMA20-14.09% SMA50-6.37% SMA200-17.00% Volume278,662 Change-2.83%
Dec-23-19Initiated ROTH Capital Buy $37
Feb-14-19Initiated H.C. Wainwright Buy $35
Aug-13-18Initiated Piper Jaffray Overweight $40
Aug-13-18Initiated Leerink Partners Outperform $43
Aug-13-18Initiated JP Morgan Neutral $29
May-27-20 07:30AM  
May-14-20 08:51AM  
May-08-20 09:01AM  
Apr-17-20 04:05PM  
12:00PM  
Apr-15-20 12:22AM  
Apr-14-20 04:05PM  
Apr-07-20 07:55AM  
Apr-06-20 04:30PM  
Mar-09-20 04:10PM  
Mar-04-20 12:30PM  
Feb-19-20 07:30AM  
Jan-28-20 07:11AM  
Jan-08-20 07:30AM  
Dec-14-19 08:42PM  
Nov-26-19 04:05PM  
Nov-12-19 06:15PM  
04:04PM  
Nov-05-19 10:31AM  
Oct-30-19 10:57AM  
Oct-28-19 11:31AM  
Sep-25-19 07:30AM  
Sep-12-19 08:40AM  
Sep-03-19 04:05PM  
Aug-13-19 06:15PM  
04:14PM  
Jul-30-19 02:35PM  
Jul-29-19 07:30AM  
Jul-16-19 09:05AM  
May-21-19 07:30AM  
May-13-19 04:11PM  
May-07-19 12:54PM  
Mar-19-19 07:30AM  
Mar-18-19 07:30AM  
Mar-14-19 04:27PM  
Mar-13-19 04:05PM  
Feb-21-19 07:30AM  
Jan-16-19 10:16AM  
Jan-08-19 12:50PM  
Jan-02-19 04:05PM  
Nov-21-18 08:20AM  
Nov-20-18 07:30AM  
Nov-13-18 04:05PM  
Sep-26-18 04:05PM  
Aug-30-18 04:07PM  
Jul-20-18 04:05PM  
Jul-19-18 08:00AM  
Jul-18-18 11:37AM  
07:27AM  
Jul-17-18 06:55PM  
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, which is in Phase I clinical trials used for the treatment of acromegaly and neuroendocrine tumors. The company is also developing CRN01941, an oral selective nonpeptide sst2 biased agonist designed for the treatment of neuroendocrine tumors; an oral selective nonpeptide somatostatin type 5 receptor agonist for treating congenital hyperinsulinism; and an oral adrenocorticotrophic hormone antagonist for the treatment of cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WIERENGA WENDALLDirectorApr 28Option Exercise0.7325,32918,49099,846Apr 29 05:01 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 17Buy14.001,071,42814,999,9923,659,381Apr 20 08:30 AM
Vivo Capital VIII, LLC10% OwnerApr 17Sale15.4084,5981,302,809298,625Apr 17 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 16Sale15.2030,190458,888308,890Apr 17 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 15Sale15.50215,8103,345,055312,553Apr 17 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 07Sale14.206,11586,833338,738Apr 07 07:27 PM
Vivo Capital VIII, LLC10% OwnerApr 03Sale13.80300,0004,140,000339,480Apr 07 07:27 PM
Vivo Capital VIII, LLC10% OwnerMar 09Sale19.5052810,296168,165Mar 11 05:12 PM
Vivo Capital VIII, LLC10% OwnerFeb 10Sale21.407,555161,677168,298Feb 11 08:00 PM
Vivo Capital VIII, LLC10% OwnerFeb 07Sale22.005,905129,910174,202Feb 11 08:00 PM
Vivo Capital VIII, LLC10% OwnerFeb 04Sale22.8013,460306,888178,816Feb 06 07:22 PM
Vivo Capital VIII, LLC10% OwnerJan 31Sale21.705,400117,180189,335Jan 31 08:00 PM
Vivo Capital VIII, LLC10% OwnerJan 30Sale22.107,600167,960193,555Jan 31 08:00 PM
Vivo Capital VIII, LLC10% OwnerJan 29Sale22.2013,920309,024199,495Jan 31 08:00 PM
Fust Matthew KDirectorDec 16Option Exercise1.913,5006,68516,036Dec 18 06:32 PM
Fust Matthew KDirectorDec 16Sale22.503,50078,75012,536Dec 18 06:32 PM